Expression of TGFβ1 and its receptors,Smad3 andSmad7 in rats with experi-mental liver fibrosis

宋仕玲,龚作炯,张全荣
DOI: https://doi.org/10.3969/j.issn.1009-3079.2004.03.041
2004-01-01
World Chinese Journal of Digestology
Abstract:AIM: To investigate the expression of TGFβ1, TGFR I, TGFR II, Smad3, Smad7 in fibrotic liver induced by the exposure of carbon tetrachloride (CCl4) in rats. METHODS: A total of 24 Wistar rats were randomly allocated into two study groups: normal group and model group-CCl4 rats. The latter group was administered with CCL4 solution to induce liver fibrosis. All the rats were killed after 8 weeks. The level of TGFβ1, TGFR I and TGFR II mRNA were examined by RT-PCR. The expression of TGF-β1, Smad3 and Smad7 were detected by immunohistochemical staining in liver tissue. The serum hyalauronic acid (HA) and the liver histopathology were also examined by RIA and HE staining respectively. RESULTS: In comparison with the normal group, TGFβ1, TGFR I and TGFR II mRNA were significantly increased in model rats, the expression of TGF-β1 and Smad3 was increased and the expression of Smad7 was decreased in livers of the model group (TGF-β1, Smad3 and Smad7 in normal and model group were 0.61±0.33 vs 1.57±0.53, 0.248±0.042 vs 0.785±0.904, 4.674±1.143 vs 0.470±0.097 respectively, P <0.05). The content of serum HA was increased in model rats (HA in normal and model group was (78.4±19.2 μg/L) vs (263.2±107.0) μg/L, P <0.01). The histological changes of fibrosis was also remarkable. CONCLUSION: TGFβ1/TGF receptors/Smad signaling involve the formation and development of liver fibrosis. The TGFβ1/Smad signal pathway plays key roles in liver fibrogensis. It may be a new pathway for the treatment of liver fibrosis.
What problem does this paper attempt to address?